Back
CRISPR Therapeutics AG Stock Price Chart
Sponsored
CRSP
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
CRSP
CRISPR Therapeutics AG
Last Price:
49.41
Seasonality Move:
3.26%
7 Day Trial
ALL ACCESS PASS
$
7
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options- The current trend is relatively stagnant and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
CRISPR Therapeutics AG Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.24 | Buy |
20-day SMA: | 47.24 | Buy |
50-day SMA: | 50.94 | Sell |
200-day SMA: | 60.86 | Sell |
8-day EMA: | 47.92 | Buy |
20-day EMA: | 47.76 | Buy |
50-day EMA: | 50.17 | Sell |
200-day EMA: | 56.34 | Sell |
CRISPR Therapeutics AG Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.56 | Sell |
Relative Strength Index (14 RSI): | 54.66 | Buy |
Chaikin Money Flow: | -1124988 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.74 - 49.2) | Buy |
Bollinger Bands (100): | (48.75 - 58.61) | Sell |
CRISPR Therapeutics AG Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
- CRISPR Therapeutics AG share price is 49.55 while CRSP 8-day simple moving average is 47.24, which is a Buy signal.
- The stock price of CRSP is 49.55 while CRISPR Therapeutics AG 20-day SMA is 47.24, which makes it a Buy.
- CRISPR Therapeutics AG 50-day simple moving average is 50.94 while CRSP share price is 49.55, making it a Sell technically.
- CRSP stock price is 49.55 and CRISPR Therapeutics AG 200-day simple moving average is 60.86, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
44
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a Sell
The current CRISPR Therapeutics AG [CRSP] share price is $49.55. The Score for CRSP is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
4.22B
Price in USD:
49.55
Share Volume:
1.53M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
91.10
52-Week Low:
37.55
Sell
44
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?
The CRISPR Therapeutics AG stock price is 49.55 USD today. -
Will CRSP stock go up or go down?
CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators -
Is CRISPR Therapeutics AG overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
- CRISPR Therapeutics AG share price is 49.55 while CRSP 8-day exponential moving average is 47.92, which is a Buy signal.
- The stock price of CRSP is 49.55 while CRISPR Therapeutics AG 20-day EMA is 47.76, which makes it a Buy.
- CRISPR Therapeutics AG 50-day exponential moving average is 50.17 while CRSP share price is 49.55, making it a Sell technically.
- CRSP stock price is 49.55 and CRISPR Therapeutics AG 200-day simple moving average is 56.34, creating a Sell signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
- Analysts estimate an earnings decrease this quarter of $0.54 per share, an increase next quarter of $0.01 per share, a decrease this year of $2.74 per share, and an increase next year of $0.41 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
- CRSP Moving Average Covergence Divergence (MACD) indicator is -0.56, suggesting CRISPR Therapeutics AG is a Sell
- CRISPR Therapeutics AG Relative Strength Index (RSI) is 54.66, which suggest CRISPR Therapeutics AG is overbought
- The Bollinger Bands (25) for CRISPR Therapeutics AG is (45.74 - 49.2), which suggest CRISPR Therapeutics AG is a Sell
- The Bollinger Bands (100) for CRISPR Therapeutics AG is (48.75 - 58.61), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.